The CML Advocates Network was pleased to participate in the European Hematology Association (EHA) Congress 2026, where members of our community joined leading clinicians, researchers, industry representatives, and patient advocates from around the world.
Throughout the congress, CMLAN staff, Steering Committee members and CMLAN member organisations attended scientific sessions focused on treatment advances, patient-reported outcomes, treatment-free remission, quality of life, and emerging research in CML. We also had the opportunity to meet with many of the companies active in the CML field, strengthening dialogue and collaboration around the future needs of patients worldwide.
As part of our commitment to making scientific developments accessible to the patient community, we have prepared a short video podcast summarizing the key CML highlights presented during EHA 2026.
EHA 2026 CML Highlights Podcast
In this special EHA 2026 video podcast we help break down the CML sessions at this year’s EHA. It’s a useful way to understand the most important CML presentations from the congress, including emerging clinical data, treatment developments, and topics that matter most to patients and advocates. It is also available with Spanish subtitles.
Watch the podcast here:
Podcast con subtitulos en Español:
We encourage all members and patient advocates who were unable to attend EHA to watch the recording and stay informed about the latest developments in CML care and research.
If you would like further details we have also developed a written report which provides a high-level summary of the main CML sessions at EHA 2026. Some highlights include the topics of treatment choices, molecular monitoring, quality of life, treatment-free remission, and findings of practical relevance to patients and patient advocates. We have also made this report available in Spanish.
